Gb Sciences gets US patent for cannabinoid-containing mixture to treat heart disease

Eoneren/E+ via Getty Images

• Gb Sciences (OTCQB:GBLX) was issued a new patent by the U.S. Patent and Trademark Office (USPTO) for a cannabinoid-containing mixture designed to treat cardiac hypertrophy, often present in advanced heart disease.
• Cardiac hypertrophy is the enlargement and thickening of the walls of the heart leading to difficulty in pumping blood.
• The company said the patent also covers the use of these receptor-targeted formulations for treating TRPV1-receptor-associated hearing loss and urinary cystitis.